Doreen Ho

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Pain perception and nonsuicidal self-injury: A laboratory investigation.

Jill M. Hooley, Doreen Ho, Joshua A. Slater et al. · Personality Disorders Theory Research and Treatment · 2010 · 238 citations

Social Sciences, Behavioral Sciences, Psychology +15

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

James F. Howard, Richard J. Nowak, Gil I. Wolfe et al. · JAMA Neurology · 2020 · 193 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Risk of Confirmed Guillain-Barre Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009-2010

Sharon K. Greene, Melisa D. Rett, Eric Weintraub et al. · American Journal of Epidemiology · 2012 · 90 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9